Pulnovo Medical: $100 Million Raised From Medtronic For Pulmonary Hypertension And Heart Failure Therapies
By Amit Chowdhry ● Apr 20, 2026
Pulnovo Medical, a medical technology company focused on breakthrough therapies for pulmonary hypertension and heart failure, announced the completion of an oversubscribed $100 million strategic financing round led by Medtronic. The round also included continued participation from existing investors EQT, Qiming Venture Partners, Gaorong Ventures, OrbiMed, and Lilly Asia Ventures, along with new investors including HSG and other global backers.